ACUTA CAPITAL PARTNERS, LLC Portfolio

Auto-discovered active 13F filer.

SEC 13F CIK: 0001582844

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q4 2024 · 39 positions · Total reported value $99.40M · Top-10 concentration 60.4% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 52.9% · 11 new · 7 cut · 0 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -16.4% · vs SPY -18.5% · Prev Value $143.49M — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -8.3% · vs SPY -10.5% · Latest Value $126.75M — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2024 13F filing, ACUTA CAPITAL PARTNERS, LLC disclosed 39 equity positions with a combined reported value of $99.40M. The filing implies a focused portfolio: its ten largest positions account for 60.4% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2024 were OCUL ($9.49M), INSM ($7.24M), TRML ($7.14M). By sector, the heaviest allocations are Health Care 75.6%, Other 24.4%. Versus the prior quarter, allocation shifted toward Health Care (+1.0pp) and away from Other (-1.0pp).

Versus the prior quarter, ACUTA CAPITAL PARTNERS, LLC opened 11 new positions, trimmed 7 and fully exited 0, a turnover rate of 52.9% of positions. The portfolio's overlap with the prior quarter was 63% of names.

The largest new positions opened in Q4 2024 were DRUG ($2.49M), CDTX ($1.46M), NAMS ($1.28M).

Of the 8 positions fully exited versus the prior quarter, the largest were KURA ($3.85M), CMPS ($2.43M), SLRN ($1.79M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • DRUG BRIGHT MINDS BIOSCIENCES INC · $2.49M
  • CDTX CIDARA THERAPEUTICS INC · $1.46M
  • NAMS NEWAMSTERDAM PHARMA COMPANY · $1.28M
  • ZYME ZYMEWORKS INC · $984.39K
  • ELDN ELEDON PHARMACEUTICALS INC · $971.29K
  • SGMOQ SANGAMO THERAPEUTICS INC · $754.80K
  • FBRX FORTE BIOSCIENCES INC · $411.94K
  • CRVS CORVUS PHARMACEUTICALS INC · $397.54K

Fully Exited (vs previous quarter)

  • KURA KURA ONCOLOGY INC · prev qtr: $3.85M
  • CMPS COMPASS PATHWAYS PLC · prev qtr: $2.43M
  • SLRN ACELYRIN INC · prev qtr: $1.79M
  • DYN DYNE THERAPEUTICS INC · prev qtr: $1.66M
  • GERN GERON CORP · prev qtr: $703.25K
  • CRBP CORBUS PHARMACEUTICALS HLDGS · prev qtr: $381.65K
  • CYPH CYPHERPUNK TECHNOLOGIES INC · prev qtr: $309.69K
  • CLYM CLIMB BIO INC · prev qtr: $274.86K

Insider Transactions (Form 4)

Latest ACUTA CAPITAL PARTNERS, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Acuta Capital Partners, based in Redwood City, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 23 positions worth $143.49M in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: REDWOOD CITY, CA, United States
  • SEC registration: 801-136966 (status: Approved), registered 2026-09-09
  • Regulatory AUM (Form ADV): $172.53M as of 2026-06-30
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 2 hedge funds
  • Website: acutacapital.com

Portfolio Structure

  • 23 positions · $143.49M reported value (Q2 2026)
  • Top 10 holdings = 73.7% of reported value
  • Largest position: PRAX (PRAXIS PRECISION MEDICINES I) at 19.3%
  • Average position size: $6.24M

Sector Tilt

  • Health Care 100.0%
  • (classified holdings cover 100% of value)

Quarterly Activity

  • Q2 2026: 4 new, 7 added, 6 reduced, 7 exited
  • 6 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 75.6%
Other 24.4%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 1.11M $9.49M 9.54%
9.54%
Reduce
2 104.80K $7.24M 7.28%
7.28%
Reduce
3 351.84K $7.14M 7.18%
7.18%
Add
4 122.90K $6.28M 6.32%
6.32%
Reduce
5 267.37K $6.02M 6.05%
6.05%
Reduce
6 1.85M $5.83M 5.87%
5.87%
Hold
7 67.50K $5.19M 5.23%
5.23%
Add
8 111.70K $4.89M 4.92%
4.92%
Add
9 6.91K $4.25M 4.28%
4.28%
Add
10 45.00K $3.68M 3.71%
3.71%
Reduce
11 771.96K $3.18M 3.20%
3.20%
Add
12 22.98K $3.16M 3.18%
3.18%
Add
13 779.31K $2.73M 2.74%
2.74%
Reduce
14 69.12K $2.49M 2.50%
2.50%
New
15 447.50K $2.48M 2.49%
2.49%
Reduce
16 87.66K $2.34M 2.35%
2.35%
Add
17 180.94K $1.90M 1.91%
1.91%
Hold
18 2.30M $1.83M 1.84%
1.84%
Add
19 134.50K $1.69M 1.70%
1.70%
Reduce
20 137.71K $1.62M 1.63%
1.63%
Add
21 1.12M $1.60M 1.61%
1.61%
Reduce
22 884.24K $1.53M 1.54%
1.54%
Reduce
23 33.01K $1.52M 1.53%
1.53%
Add
24 54.47K $1.46M 1.47%
1.47%
New
25 50.00K $1.28M 1.29%
1.29%
New
26 67.24K $984.39K 0.99%
0.99%
New
27 235.75K $971.29K 0.98%
0.98%
New
28 160.20K $903.53K 0.91%
0.91%
Add
29 21.00K $883.47K 0.89%
0.89%
Reduce
30 9.15K $845.19K 0.85%
0.85%
Reduce
31 10.74K $823.88K 0.83%
0.83%
Reduce
32 740.00K $754.80K 0.76%
0.76%
New
33 49.80K $512.44K 0.52%
0.52%
Add
34 44.00K $443.52K 0.45%
0.45%
Hold
35 18.14K $411.94K 0.41%
0.41%
New
36 74.31K $397.54K 0.40%
0.40%
New
37 25.00K $327.25K 0.33%
0.33%
Reduce
38 16.40K $290.94K 0.29%
0.29%
Reduce
39 90.83K $20.89K 0.02%
0.02%
Hold

FAQ

What did ACUTA CAPITAL PARTNERS, LLC buy in 2024-Q4?

In its 2024-Q4 13F filing, ACUTA CAPITAL PARTNERS, LLC reported 39 equity positions worth $99.40M in aggregate; its largest disclosed positions were OCUL ($9.49M), INSM ($7.24M), TRML ($7.14M).

How large is ACUTA CAPITAL PARTNERS, LLC's portfolio?

ACUTA CAPITAL PARTNERS, LLC reported $99.40M of long equity holdings across 39 positions as of 2024-Q4. Top-10 holdings account for 60.4% of reported value.

What is ACUTA CAPITAL PARTNERS, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/acuta-capital-partners/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →